DNY59/E+ via Getty Images Topline Summary and Update TriSalus Life Sciences, Inc. (NASDAQ:TLSI) is a device manufacturer focused on developing the commercial ground for their organ-targeted therapy delivery mechanism. While they've had devices launched for several years, the company is continuing to work toward getting a drug of their own that pairs well. As hype has deflated since my first coverage of the company back in January, it is worth revisiting the investment thesis to see if they are now more of a ...